ConductScience.org, home

Paper3975652

Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.

Morgan LR. Semin Oncol, 1985. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. Papers, record 3975652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3975652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
PubMed
Journal
Semin Oncol
PubMed
Year
1985
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
2.64
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morgan LRL R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
MegestrolMajor topic
TamoxifenMajor topic
Adult
Aged
Female
Humans
Megestrol Acetate
Menopause
Middle Aged
Receptors, Estrogen
Receptors, Progesterone

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
34638457Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.Cancers (Basel)2021https://conductscience.org/library/papers/34638457PubMed
30410061Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.Br J Cancer2018https://conductscience.org/library/papers/30410061PubMed
30181360Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer.Genes Dev2018https://conductscience.org/library/papers/30181360PubMed
27885264Deciphering the divergent roles of progestogens in breast cancer.Nat Rev Cancer2017https://conductscience.org/library/papers/27885264PubMed
26884552Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer.Eur J Endocrinol2016https://conductscience.org/library/papers/26884552PubMed
23443928
Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement.
Curr Oncol2013https://conductscience.org/library/papers/23443928PubMed
22317766The sequential use of endocrine treatment for advanced breast cancer: where are we?Ann Oncol2012https://conductscience.org/library/papers/22317766PubMed
8558464Residual Ca2+ channel current modulation by megestrol acetate via a G-protein alpha s-subunit in rat hypothalamic neurones.J Physiol1995https://conductscience.org/library/papers/8558464PubMed
7613532The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.Qual Life Res1995https://conductscience.org/library/papers/7613532PubMed
2690972Megestrol acetate versus aminoglutethimide for metastatic breast cancer.Breast Cancer Res Treat1989https://conductscience.org/library/papers/2690972PubMed
2249324Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2249324PubMed
2095927Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.Breast Cancer Res Treat1990https://conductscience.org/library/papers/2095927PubMed
1756260A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.Breast Cancer Res Treat1991https://conductscience.org/library/papers/1756260PubMed
1505141Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.Clin Pharmacokinet1992https://conductscience.org/library/papers/1505141PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3975652

GET https://conductscience.org/api/papers/v1/3975652/authors